Mirum Pharmaceuticals, Inc. MIRM Accrued contract manufacturing and non-clinical costs
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept mirm:AccruedContractManufacturingAndNonClinicalCostsCurrent.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs?
- Mirum Pharmaceuticals, Inc. (MIRM) reported accrued contract manufacturing and non-clinical costs of $18.28M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs increased by 120.2% year-over-year, from $8.3M to $18.28M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs?
- Over 2 years (2023 to 2025), Mirum Pharmaceuticals, Inc.'s accrued contract manufacturing and non-clinical costs has grown at a -6.2% compound annual growth rate (CAGR), from $9.92M to $8.72M.